Our results from the measurement of RAC1 activity in primary tumor by immunofluorescence suggest that high RAC1 activity could be predictive of metastasis relapses in breast cancer with a high specificity and sensitivity in TNBC. The gene discussed is RAC1; the disease is breast cancer.